Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
Department of Cardiology, Radboud University Medical Center and Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Europace. 2022 Apr 5;24(4):565-575. doi: 10.1093/europace/euab229.
In atrial fibrillation (AF) patients, untreated sleep-disordered breathing (SDB) is associated with lower success rates of rhythm control strategies and as such structured SDB testing is recommended. Herein, we describe the implementation of a virtual SDB management pathway in an AF outpatient clinic and examine the utility and feasibility of this new approach.
Prospectively, consecutive AF patients accepted for AF catheter ablation procedures without previous diagnosis of SDB were digitally referred to a virtual SDB management pathway and instructed to use WatchPAT-ONE (ITAMAR) for one night. Results were automatically transferred to a virtual sleep laboratory, upon which a teleconsultation with a sleep physician was planned. Patient experience was measured using surveys. SDB testing was performed in 119 consecutive patients scheduled for AF catheter ablation procedures. The median time from digital referral to finalization of the sleep study report was 18 [11-24] days. In total, 65 patients (55%) were diagnosed with moderate-to-severe SDB. Patients with SDB were prescribed more cardiovascular drugs and had higher body mass indices (BMI, 29 ± 3.3 vs. 27 ± 4.4kg/m2, P < 0.01). Patients agreed that WatchPAT-ONE was easy to use (91%) and recommended future use of this virtual pathway in AF outpatient clinics (86%). Based on this remote SDB testing, SDB treatment was recommended in the majority of patients.
This novel virtual AF management pathway allowed remote SDB testing in AF outpatient clinics with a short time to diagnosis and high patient satisfaction. Structured SDB testing results in a high detection of previously unknown SDB in AF patients scheduled for AF ablation.
在心房颤动(AF)患者中,未经治疗的睡眠呼吸障碍(SDB)与节律控制策略成功率较低相关,因此推荐进行结构化 SDB 测试。在此,我们描述了在 AF 门诊中实施虚拟 SDB 管理途径的情况,并检验了这种新方法的实用性和可行性。
前瞻性地,连续接受 AF 导管消融术而无 SDB 既往诊断的 AF 患者被数字转诊至虚拟 SDB 管理途径,并被指示使用 WatchPAT-ONE(ITAMAR)进行一夜睡眠监测。结果自动传输至虚拟睡眠实验室,随后计划与睡眠医师进行远程会诊。使用问卷调查来测量患者体验。对 119 例连续接受 AF 导管消融术的患者进行了 SDB 测试。从数字转诊到睡眠研究报告最终确定的中位时间为 18 [11-24] 天。共有 65 例患者(55%)被诊断为中重度 SDB。SDB 患者服用的心血管药物更多,体重指数(BMI)更高(29 ± 3.3 与 27 ± 4.4kg/m2,P < 0.01)。患者认为 WatchPAT-ONE 易于使用(91%),并推荐在 AF 门诊中未来使用这种虚拟途径(86%)。基于这种远程 SDB 测试,大多数患者都推荐进行 SDB 治疗。
这种新颖的虚拟 AF 管理途径允许在 AF 门诊中进行远程 SDB 测试,诊断时间短,患者满意度高。结构化 SDB 测试结果显示,在接受 AF 消融术的 AF 患者中,先前未知的 SDB 检出率很高。